Milene Saavedra, MD
Dr. Milene Saavedra is a board-certified pulmonologist and researcher who specializes in cycstic fibrosis.
- Associate Professor
- Department of Medicine
- Division of Pulmonary, Critical Care & Sleep Medicine
- 2024 Top Doctor – 5280 Magazine & Castle Connolly
Patient Ratings
5 out of 5
Programs and Services
Specialties & Conditions
Research AreasSpecial Interests
Research Interests
Cystic Fibrosis, biomarkers of lung inflammation, adaptive immune responses in cystic fibrosis
Education
Education
- University of Florida College of Medicine, MD
Residency
- Washington University, Residency
Awards & Recognition
2015: Best Doctors in America, Best Doctors, Inc.
Board Certification
Internal Medicine
Pulmonary
Critical Care Medicine
Publications
Saavedra MT, Lynch DA. Emerging roles for CT imaging in cystic fibrosis. Radiology. 2009 Aug;252(2):327-9. Zander KA, Saavedra MT, West J, Scapa V, Sanders L, Kingdom TT. Protein microarray analysis of nasal polyps from aspirin-sensitive and aspirin-tolerant patients with chronic rhinosinusitis. Am J Rhinol Allergy. 2009 May-Jun; 23(3):268-72.
Saavedra MT, Hughes GD, Sanders L, Carr M, Rodman DM, Coldren C, Accurso FJ, West J, Nick JA. Circulating RNA transcripts characterize therapeutic response in Cystic Fibrosis lung disease Am. J. Respir. Crit. Care Med. 2008; 2008 Nov 1.
Fulcher ML, Gabriel SE, Olsen JC, Tatreau JR, Gentzsch M, Livanos E, Saavedra MT, Salmon P, Randell SH, Novel human bronchial epithelial line for cystic fibrosis research, Am J Physiol Lung Cell Mol Physiol. 2008 Oct 31.
Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, Dinarello, CA. Endogenous IL-32 controls cytokine and HIV-1 production. J Imm. 2008 Jul l;181(1):557-65.
Hospital Affiliations
- St. Joseph Hospital - Denver
- University of Colorado Hospital
Academic Affiliations
Affiliate Faculty, University of Colorado Denver, Division of Pulmonary and Critical Care
Teaching & Professional Positions
Associate Director, Adult Cystic Fibrosis Center
Conflicts of Interest
National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.
The Patient metric-rating score is an average of all responses to
care provider related questions on our independent metric-rating
system, the Press Ganey Patient Satisfaction Survey. This survey is
about the patient care experience and does not address crucial
characteristics like medical decision-making, prescribing the best
therapy, and patient outcomes.
